Drug intelligence / Profile preview

TC100

Development stage: Unknown
Lead developer: Tilray
Modality: Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

**TC100** is a Tilray-manufactured oral cannabis oil product marketed in Chile for chronic pain under prescription. It contains delta-9-tetrahydrocannabinol and cannabidiol in a balanced cannabinoid formulation; contemporaneous reports describe it as an oil solution containing both THC and CBD, although reported concentrations varied between sources. THC is a partial agonist of cannabinoid receptors CB1 and CB2, while CBD has a multimodal pharmacology that includes negative allosteric modulation of CB1. ([biobiochile.cl](https://www.biobiochile.cl/noticias/nacional/chile/2017/08/24/acuerdo-permitira-que-medicamentos-en-base-a-cannabis-lleguen-por-primera-vez-a-todo-chile.shtml))

Brand names: TC100TC-100TC 100

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on TC100.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TC100.

Explore the full profile